These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31517549)

  • 1. The effect of early vs. delayed postpartum insertion of the LNG-IUS on breastfeeding continuation: a systematic review and meta-analysis of randomised controlled trials.
    Abdelhakim AM; Sunoqrot M; Amin AH; Nabil H; Raslan AN; Samy A
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):327-336. PubMed ID: 31517549
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in continuation rates and early removal between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg.
    Teunissen AM; Merry AHH; Devies IEC; Roumen FJME
    Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):449-456. PubMed ID: 31696740
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomised clinical trial to assess satisfaction with the levonorgestrel- releasing intrauterine system inserted at caesarean section compared to postpartum placement.
    Braniff K; Gomez E; Muller R
    Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):279-83. PubMed ID: 26053465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate versus delayed initiation of the levonorgestrel-releasing intrauterine system following medical termination of pregnancy - 1 year continuation rates: a randomised controlled trial.
    Korjamo R; Mentula M; Heikinheimo O
    BJOG; 2017 Dec; 124(13):1957-1964. PubMed ID: 28650566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.
    Hubacher D; Masaba R; Manduku CK; Chen M; Veena V
    Contraception; 2015 Apr; 91(4):295-300. PubMed ID: 25601351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expulsions and adverse events following immediate and later insertion of a levonorgestrel-releasing intrauterine system after medical termination of late first- and second-trimester pregnancy: a randomised controlled trial.
    Korjamo R; Mentula M; Heikinheimo O
    BJOG; 2017 Dec; 124(13):1965-1972. PubMed ID: 28692170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.
    Todd CS; Jones HE; Langwenya N; Hoover DR; Chen PL; Petro G; Myer L
    PLoS Med; 2020 May; 17(5):e1003110. PubMed ID: 32442189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
    Abou-Setta AM; Al-Inany HG; Farquhar CM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005072. PubMed ID: 17054236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-week postpartum intrauterine contraception insertion: a study of feasibility, patient acceptability and short-term outcomes.
    Zerden ML; Stuart GS; Charm S; Bryant A; Garrett J; Morse J
    Contraception; 2017 Jan; 95(1):65-70. PubMed ID: 27554014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
    Borgatta L; Buhling KJ; Rybowski S; Roth K; Rosen K
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review.
    Wan YL; Holland C
    Climacteric; 2011 Dec; 14(6):622-32. PubMed ID: 22017273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
    French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
    Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners.
    Nanda G; Rademacher K; Solomon M; Mercer S; Wawire J; Ngahu R
    Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):303-308. PubMed ID: 30198796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial.
    Turok DK; Leeman L; Sanders JN; Thaxton L; Eggebroten JL; Yonke N; Bullock H; Singh R; Gawron LM; Espey E
    Am J Obstet Gynecol; 2017 Dec; 217(6):665.e1-665.e8. PubMed ID: 28842126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate postpartum insertion of intrauterine device for contraception.
    Lopez LM; Bernholc A; Hubacher D; Stuart G; Van Vliet HA
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003036. PubMed ID: 26115018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.